Gabelli & Co Investment Advisers’s Audentes Therapeutics, Inc BOLD Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio BOLD Stock Details BOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-334,869	Closed	-$20M	–	228
2019 Q4	$20M	Buy	+334,869	New	+$12.6M	2.32%	13

Gabelli & Co Investment Advisers's BOLD Position: Q1 2020 in Review

Gabelli & Co Investment Advisers sold out of Audentes Therapeutics, Inc (BOLD) in Q1 2020, closing a stake of 334,869 shares — an estimated $20M sold.

Gabelli & Co Investment Advisers first reported a position in BOLD in Q4 2019 and held it in 1 quarter. The position peaked at $20M in Q4 2019. 0 funds tracked by Wall St. Rank hold BOLD as of Q1 2020.

Gabelli & Co Investment Advisers reported no remaining Audentes Therapeutics, Inc position as of Q1 2020 after selling out during the quarter.
Gabelli & Co Investment Advisers sold 334,869 Audentes Therapeutics, Inc shares in Q1 2020, an estimated $20M.
Gabelli & Co Investment Advisers first reported a position in Audentes Therapeutics, Inc in Q4 2019 and held it in 1 quarter.
Gabelli & Co Investment Advisers's Audentes Therapeutics, Inc position peaked at $20M in Q4 2019.
0 funds tracked by Wall St. Rank held Audentes Therapeutics, Inc as of Q1 2020.

Based on Gabelli & Co Investment Advisers's 13F filing for Q1 2020, filed 14 May 2020.